There were 2,252 press releases posted in the last 24 hours and 440,040 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Helix BioPharma Corp. Announces Regulatory Approval to Dose Patients in a Phase II Randomized Study of L-DOS47 With Vinorelbine and Cisplatin

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image